Company intelligence / Profile preview

Gene Bio-Medical

Vancouver, British Columbia, Canada

Ownership: Private
Employees: ~26
Development stage: Other

Overview

Commercial-stage diagnostics company focused on molecular diagnostic tests for infectious diseases, including SARS-CoV-2 rapid tests with over 48 million kits delivered during COVID-19. Respiratory product line pending FDA approval in 2025.

Industry: Molecular Diagnostics

Partnerships

BIDIPHAR (joint venture for manufacturing in Vietnam)

Beyond the preview

Go deeper on Gene Bio-Medical.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Gene Bio-Medical.

Explore the full profile